Is Molecular Characterization Useful for Targeted Therapy Orientation in Patients with Relapsed or Refractory DLBCL Included in Early Phase Clinical Trials?
Year: 2020
Type: article
Study design: Observational Study
Source: Blood
Authors: Jean-Marie Michot, Valérie Camara-Clayette, Cyril Quivoron, Alina Danu, Julien Lazarovici, David Ghez, Julien Rossignol, Capucine Baldini, Patricia Martin-Romano, Clementine Sarkozy, Andrea Varga, Helene Lecourt, Veronique Vergé, Sophie Cotteret, Peggy Dartigues-Cuillères, Christophe Massard, Vincent Ribrag
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095453422